Sana Health is an audio-visual neuromodulation device, that provides anxiety relief on-demand - multiple applications in pain and mental health, 2 pivotal studies are underway in Fibromyalgia (FDA designated breakthrough device) and Neuropathic Pain. Anxiety and PTSD trials starting in Q2 2022, DoD grant for PTSD. SOSV, Founders Fund, Noetic Fund, Harmonix, Dreamit, Esplanade, Bridge Builders Collective, Menlo Ventures.

Biosensor is a limited liability company that was founded in 2003 as a spin-off of DAS from a strategic idea aimed at developing the high technology business in order to differentiate itself from the crisis that has taken place in the traditional field of electromedical devices that occurred in the mid-1990s. The headquarters of the Biosensor is in the industrial area of Formello (Cassia-Rome) where since 2008 has been designing, developing, industrial research and the production of its prototypes. Biosensor is equipped with 400 square meters of fully-equipped laboratories.

Otologics, LLC, a medical device company, develops and manufactures amplification products that are designed to improve communication of life for individuals with hearing loss. It offers Carina, an implantable treatment option for hearing loss. The company was founded in 1996 and is headquartered in Boulder, Colorado.

Cognito Therapeutics, Inc. is an American company located in Cambridge, MA. The firm develops digital therapeutics to treat neurodegenerative disorders. It was founded by Li-Huei Tsai and Ed Boyden. Brent A. Vaughan is the current CEO, occupying that position since 2020.\nThe company says this about itself: Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders. Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. The Company?s lead therapy is currently in a pivotal study (HOPE) in Alzheimer?s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA.

MedRhythms, Inc. is an American company located in Portland, ME. The firm provides digital therapeutics services. It was founded in 2013 by Brian Harris and Owen McCarth. Brian Harris has been the CEO since then.\nThe company says this about itself: MedRhythms, a privately held company headquartered in Portland, ME, is a digital therapeutics company that uses sensors, music, and software to build evidence-based, neurologic interventions to measure and improve walking. MedRhythms is dedicated to developing direct stimulation digital therapeutics, meaning that each therapeutic provides, via prescription music, direct stimulation to enable the mechanism of action in each relevant population. The company has an active pipeline of prescription digital therapeutics targeting rehabilitation and prevention in areas of neurologic injury and disease. The MedRhythms team has extensive experience in rehabilitation techniques utilizing music. The company has roots as a therapy services company that launched out of Spaulding Rehabilitation Hospital, which the U.S. News & World Report named the No. 2 ranked rehabilitation hospital in the country.

Oncomfort’s solution for digital sedation is a completely new method for relieving patients’ pain and anxiety before, during and after medical procedures. This revolutionising digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

National Rehabilitation Center is a Korean public health agency that oversees treatment, rehabilitation research, education and training.

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy.

Advanced Bionics Corp. develops, manufactures, and markets bionic technologies for neurological conditions. Its neuromodulation technology includes neurostimulators, programmable drug pumps, and cochlear implants. The company was founded by Alfred Mann in 1993 and is headquartered in Sylmar, CA.

Forschungszentrum Jülich ("Jülich Research Centre") is a member of the Helmholtz Association of German Research Centres and is one of the largest interdisciplinary research centres in Europe. It was founded on 11 December 1956 by the state of North Rhine-Westphalia as a registered association, before it became "Kernforschungsanlage Jülich GmbH" or Nuclear Research Centre Jülich in 1967. In 1990, the name of the association was changed to "Forschungszentrum Jülich GmbH". It has close collaborations with RWTH Aachen in the form of Jülich-Aachen Research Alliance (JARA).

NEOFECT was founded in June 2010 by Hoyoung Ban and Scott Kim, two students from the University of Virginia’s Darden Graduate School of Business, and Young Choi, MS, Ph.D. of the University of Southern California, who majored in ‘stroke rehabilitation algorithm and robotics.’ NEOFECT’s flagship product, the RAPAEL Smart Glove, was released in 2014 and has been sold to many home patients in the US and the hospitals across the globe, including NewYork-Presbyterian, Department of Veterans Affairs (DVA), Shirley Ryan Abilitylab (former RIC or Rehabilitation Institute of Chicago), Brooks Rehabilitation, and Swedish Medical Center. The RAPAEL Smart Glove received FDA clearance in 2014. Other than RAPAEL Smart Glove, Neofect has launched RAPAEL Smart Pegboard, RAPAEL Smart Glove, RAPAEL Smart Board, RAPAEL Smart Kids. In 2016, NEOFECT participated in a study conducted by the National Rehabilitation Center in Korea to evaluate the impact of virtual reality-based exercises on a rehabilitation program for stroke patients. The study found VR-based rehabilitation combined with standard occupational therapy is more effective than traditional therapy alone for greater upper extremity function. NEOFECT has offices in South Korea, the U.S., and Germany. Its devices are sold in South Korea, the U.S., and all over Europe.

Oticon Medical A/S provides solutions for people with hearing loss. It offers bone anchored hearing systems, which address the needs of different patient groups. The company was founded by Inger Marie S��bye, Leif Madsen Pedersen, and John Kj��rsgaard Pedersen on August 13, 1999 and is headquartered in Smorum, Denmark.

Brainscope is a medical neurotechnology company that improves brain health. It develops a new generation of hand-held, simple-to-use, non-invasive instruments to aid medical professionals in rapidly, accurately, and objectively assessing brain function at the initial point of care. BrainScope devices in development are based on a revolutionary and proprietary technology platform, which integrates databases of brainwave recordings with advanced developments in Digital Signal Processing (DSP), sophisticated linear and non-linear algorithms, miniaturized hardware, and disposable headset sensors. It also provides objective, diagnostic insights that enable better patient care. The company’s innovative BrainScope One system is the first and only portable, EEG-based, radiation-free platform that empowers physicians to quickly make accurate head injury assessments. It was founded in 2010 and is headquartered in Bethesda, Maryland.

Based in Tel Aviv, Israel, Nuvo Group Ltd. (“Nuvo”) is committed to reinventing pregnancy care for the 21st century through new technology, tools, and practices for providers and expectant mothers, including the INVU™ by Nuvo platform, an FDA-cleared, prescription initiated remote pregnancy monitoring and management system. INVU is enabling the delivery of remote non-stress tests and maternal & fetal heart rate monitoring today while pioneering new data-driven personalized pathways that Nuvo believes will help improve health outcomes for all women in the future. The technology and patent estate that underpin the INVU platform have been awarded a number of industry recognitions, including Fast Company’s Next Big Things in Tech (2021), CB Insights’ Digital Health 150 (2020), and MedTech Innovator’s Top 50 MedTech Startups (2021), as well as multiple grants from some of the world’s leading academic medical centers and scientific bodies. Nuvo is led by a diverse team of experienced business and medical professionals, dedicated data engineers, software designers and proud parents who embrace a collective mission to give every life a better beginning.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.